Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 5.19
+0.19 (3.80%)
Jul 10, 2026, 4:08 PM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 92.53 billion as of July 10, 2026. Its market cap has increased by 3.48% in one year.
Market Cap
92.53B
Enterprise Value
97.57B
Revenue
35.43B
Ranking
n/a
PE Ratio
35.93
Stock Price
5.19
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 92.53B, an increase of 27,942.90%. That is a compound annual growth rate of 24.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 92.53B | -16.24% |
| Dec 31, 2025 | 110.48B | 89.64% |
| Dec 31, 2024 | 58.26B | -8.75% |
| Dec 29, 2023 | 63.85B | -24.41% |
| Dec 30, 2022 | 84.46B | -17.53% |
| Dec 31, 2021 | 102.41B | -27.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 263.11B |
| WuXi Biologics | 152.26B |
| Innovent Biologics | 150.10B |
| Sichuan Kelun-Biotech Biopharmaceutical | 110.76B |
| Akeso | 87.19B |
| RemeGen | 70.85B |
| Biocytogen Pharmaceuticals (Beijing) | 46.49B |
| 3SBio | 42.51B |